September 8, 2023 Columns by John Connor Youāve got a Napoleon complex, you have, mate I don’t have a Napoleon complex in the sense of being small. My body still spans 6 feet, though that’s only when I’m lying down; I doubt I get anywhere near 5 feet tall while seated in my wheelchair. Saint Jane (my wife) is 5-foot-2, and I now look…
June 10, 2022 Columns by John Connor My Right Arm Is Going to Look Really Young I’ve just received four intramuscular Botox injections in my right arm to relieve the muscle spasticity that comes with multiple sclerosis. (OK, it wasnāt actually Botox, but Dysport, or abobotulinumtoxinA, another medication derived from the botulinum toxin to block muscle contractions.) And “my right arm is going…
February 5, 2018 Social Clips by Mike Knight MS Spasticity and You: Five Stretches You Should Try (and Why) An estimated 85 percent of people with MS experience some type of spasticity due to the disease, according to a recent report (p/w) published in Multiple Sclerosis and Related Disorders. Why is that important? Because spasticity is behind many of the diseaseās most debilitating physical, emotional and mental…
January 25, 2017 News by Patricia Silva, PhD PathMaker, French Institute to Team on MyoRegulator Neuro-stimulation Clinical Trials PathMaker Neurosystems and the Brain and Spine InstituteĀ (ICM) in Paris will collaborate on human clinical trials to secure CE Mark clearance for PathMakerās MyoRegulatorĀ PM-2200, a noninvasiveĀ neurotherapy technology to treatĀ conditions linked toĀ neural pathway disruption, including multiple sclerosis (MS). CE Mark āĀ whichĀ stands for “ConformitĆ© EuropĆ©enne,” or European Conformity…
October 6, 2016 News by Patricia Silva, PhD PathMaker Wins Innovation Prize for Neurotherapies to Treat Spasticity, Muscle Weakness PathMaker Neurosystems is the winnerĀ of the Universal BiotechĀ Innovation Prize 2016Ā for its innovative, non-invasiveĀ neurotherapy technologies to treatĀ conditions linked toĀ neural pathway disruption, including multiple sclerosis (MS). The selectionĀ was announced at Innovation Days, an international event honoring the best in the life sciences andĀ heldĀ in Paris on Oct. 3ā4. Launched in 2009 byĀ a…
October 21, 2015 News by Patricia Silva, PhD Flex Pharma Presenting Data on Promising Muscle Cramp Therapeutic Agent FLX-787 at Neuroscience 2015 Flex Pharma, Inc., a biotechnology company focused on therapies for muscle cramps and spasms associated with neuromuscular conditions, recently announced that it will present new data on its therapeutic agent FLX-787 at the 2015 Annual Meeting of the Society for Neuroscience, currently taking place in Chicago (October 17ā21).